Lactoferricin-related peptides with inhibitory effects on ACE-dependent vasoconstriction

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 15, 2006, Pages 5323-5329

  Centeno, José M ^a,d   Burguete, María C ^b   Castelló Ruiz, Maria ^b   Enrique, María ^a   Vallés, Salvador ^a   Salom, Juan B ^b,c   Torregrosa, Germán ^b,c   Marcos, José F ^a   Alborch, Enrique ^b,c   Manzanares, Paloma ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

ACE inhibition; ACE dependent vasoconstriction; Ex vivo functional assay; Lactoferricin B related peptides

Indexed keywords

ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LACTOFERRICIN B; LACTOFERRIN; PEPTIDE;

ANIMAL; ARTICLE; CHEMISTRY; COMMON CAROTID ARTERY; DRUG EFFECT; IN VITRO STUDY; MALE; PHYSIOLOGY; RABBIT; VASOCONSTRICTION;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAROTID ARTERY, COMMON; LACTOFERRIN; MALE; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; RABBITS; VASOCONSTRICTION;

ORYCTOLAGUS CUNICULUS;

EID: 33746884217     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf060482j     Document Type: Article

References (41)

1. Laragh, J. H.; Bear, L.; Brunner, H. R.; Buhler, F. G.; Ealey, J. E.; Vaughan, E. D. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am. J. Med. 1972, 52, 633-652.
2. Dorer, F. E.; Kahn, J. R.; Lentz, K. E.; Levine, M.; Skeggs, L. T. Hydrolysis of bradykinin by angiotensin converting enzyme. Circ. Res. 1974, 24, 824-827.
3. Hall, J. M. Bradykinin receptors: Pharmacological properties and biological roles. Pharmacol. Ther. 1992, 56, 131-190.
4. Murphey, L. J.; Hachey, D. L.; Oates, J. A.; Morrow, J. D.; Brown, N. J. Metabolism of bradykinin in vivo in humans: Identification of BK1-5 as a stable plasma peptide metabolite. J. Pharmacol. Exp. Ther. 2000, 294, 263-269.
5. Ondetti, M. A.; Williams, N. J.; Sabo, E. F.; Pluvec, J.; Weaver, E. R.; Kocy, O. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca: Isolation, elucidation of structure and synthesis. Biochemistry 1971, 10, 4033-4039.
6. Ondetti, M. A.; Rubin, B.; Cushman, D. W. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 1977, 196, 441-444.
7. Atkinson, A. B.; Robertson, J. I. S. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 1979, 2, 836-839.
8. FitzGerald, R. J.; Murray, B. A.; Walsh, D. J. Hypotensive peptides from milk proteins. J. Nutr. 2004, 134, 980S-988S.
9. Li, G.-H.; Le, G.-W.; Shi, Y.-H.; Shrestha, S. Angiotensin-I converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutr. Res. 2004, 24, 469-486.
10. s2- casein. FEBS Lett. 2002, 531, 369-374.
11. Saiga, A.; Okumura, T.; Makihara, T.; Katsuta, S.; Shimizu, T.; Yamada, R.; Nishimura, T. Angiotensin I-converting enzyme inhibitory peptides in a hydrolyzed chicken breast muscle extract. J. Agric. Food Chem. 2003, 51, 1741-1745.
12. Lo, W. M. Y.; Li-Chan, E. C. Y. Angiotensin I-converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. J. Agric. Food Chem. 2005, 53, 3369-3376.
13. Shin, Z. I.; Yu, R.; Park, S. A.; Chung, D. K.; Nam, H. S.; Kim, K. S.; Lee, H. J. His-His-Leu, an angiotensin converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo. J. Agric. Food Chem. 2001, 49, 3004-3009.
14. Sato, M.; Hoskawa, T.; Yamaguchi, T.; Nakano, T.; Muramoto, K.; Kahra, T.; Funayama, K.; Kobayashi, A.; Nakano, T. Angiotensin I-converting enzyme inhibitory peptides derived from wakame (Undaria pinnatifida) and their antihypertensive effect in spontaneously hypertensive rats. J. Agric. Food Chem. 2002, 50, 6245-6252.
15. Marutama, S.; Miyoshi, S.; Kaneko, T.; Tanaka, H. Angiotensin I-converting enzyme inhibitory activities of synthetic peptides related to the tandem repeated sequence of a maize endosperm protein. Agric. Biol. Chem. 1989, 51, 1077-1081.
16. Kohmura, M.; Nio, N.; Ariyoshi, Y. Inhibition of angiotensin-converting enzyme by synthetic peptides of human β-casein. Agric. Biol. Chem. 1989, 53, 2107-2114.
17. Vermeirssen, V.; van Camp, J.; Verstraete, W. Bioavailability of angiotensin I-converting enzyme inhibitory peptides. Br. J. Nutr. 2004, 92, 357-366.
18. Hou, W.-C.; Chen, H.-J.; Lin, Y.-H. Antioxidant peptides with angiotensin converting enzyme inhibitory activities and applications for angiotensin converting enzyme purification. J. Agric. Food Chem. 2003, 51, 1706-1709.
19. López-García, B.; Pérez-Payá, E.; Marcos, J. F. Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library. Appl. Environ. Microbiol. 2002, 68, 2453-2460.
20. Cheung, H. S.; Wang, F. L.; Ondetti, M. A.; Sabo, E. F.; Cushman, D. W. Binding of peptide substrates and inhibitors of angiotensin-converting enzyme: Importance of the COOH-terminal dipeptide sequence. J. Biol. Chem. 1980, 255, 401-407.
21. Wu, J.; Aluko, R. E.; Nakai, S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure - activity relationship study of di- and tripeptides. J. Agric. Food Chem. 2006, 54, 732-738.
22. López-García, B.; Veyrat, A.; Pérez-Payá, E.; González-Candelas, L.; Marcos, J. F. Comparison of the activity of antifungal hexapeptides and the fungicides thiabendazole and imazalil against postharvest fungal pathogens. Int. J. Food Microbiol. 2003, 89, 163-170.
23. Tomita, M.; Wakabayashi, H.; Yamauchi, K.; Teraguchi, S.; Hayasawa, H. Bovine lactoferrin and lactoferricin derived from milk: Production and applications. Biochem. Cell Biol. 2002, 80, 109-112.
24. Tomita, M.; Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H.; Kawase, K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 1991, 74, 4137-4142.
25. Wakabayashi, H.; Takase, M.; Tomita, M. Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 2003, 9, 1277-1287.
26. Mader, J. S.; Salsman, J.; Conrad, D. M.; Hoskin, D. W. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cells Unes. Mol. Cancer Ther. 2005, 4, 612-624.
27. Schibli, D. J.; Hwang, P. M.; Vogel, H. J. The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. FEBS Lett. 1999, 446, 213-217.
28. Strom, M. B.; Haug, B. E.; Rekdal, O.; Skar, M. L.; Stensen, W.; Svendsen, J. S. Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. Biochem. Cell Biol. 2002, 80, 65-74.
29. Wu, J.; Aluko, R. E.; Muir, A. D. Improved method for direct high-performance liquid chromatography assay of angiotensin-converting enzyme-catalyzed reactions. J. Chromatogr., A 2002, 950, 125-130.
30. Cushman, D. W.; Cheung, H. S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 1971, 20, 1637-1648.
31. Tom, B.; Dendorfer, A.; Danser, A. H. J. Bradykinin, angiotensin-(1-7), and ACE inhibitors: How do they interact? Int. J. Biochem. Cell Biol. 2003, 35, 792-801.
32. Ondetti, M. A.; Cushman, D. W. Enzymes of the rennin-angiotensin system and their inhibitors. Annu. Rev. Biochem. 1982, 51, 283-308.
33. Gómez-Ruiz, J. A.; Ramos, M.; Recio, I. Angiotensin converting enzyme - inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion. Int. Dairy J. 2004, 14, 1075-1080.
34. Tomita, M.; Takase, M.; Bellamy, W.; Shimamura, S. A review: The active peptide of lactoferrin. Acta Paediatr. Jpn. 1994, 36, 585-591.
35. Fuglsang, A.; Nilsson, D.; Nyborg, N. C. B. Characterization of new milk-derived inhibitors of angiotensin converting enzyme in vitro and in vivo. J. Enzyme Inhib. Med. Chem. 2003, 18, 407-412.
36. Georgiadis, D.; Beau, F.; Czarny, B.; Cotton, J.; Yiotakis, A.; Dive, V. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: Insights for selective inhibitors. Circ. Res. 2003, 93, 148-154.
37. Zerrouk, A.; Auguet, M.; Delaflotte, S.; Chabrier, P. E. Effects of angiotensin I and angiotensin II in blood vessels: Greater influence of converting enzyme activity in the rabbit basilar artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 1996, 354, 466-473.
38. Manabe, K.; Shirahase, H.; Usui, H.; Kurahashi, K.; Fujiwara, M. Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery. J. Pharmacol. Exp. Ther. 1989, 251, 317-320.
39. Whalley, E. T. Metabolism of bradykinin and angiotensin I by human basilar artery and rabbit aorta. Naunyn-Schmiedeberg's Arch. Pharmacol. 1987, 335, 551-554.
40. Egleme, C.; Cressier, F.; Wood, J. M. Local formation of angiotensin II in the rat aorta: Effect of endothelium. Br. J. Pharmacol. 1990, 100, 237-240.
41. Chen, T.-L.; Lo, Y.-C.; Hu, W.-T.; Wu, M.-C.; Chen, S.-T.; Chang, H.-M. Microencapsulation and modification of synthetic peptides of food proteins reduces the blood pressure of spontaneously hypertensive rats. J. Agric. Food Chem. 2003, 51, 1671-1675.